Short Term Safety and Efficacy of Lubiprostone in Adults With Cystic Fibrosis

Completed 9 enrolled University of Arkansas Takeda Pharmaceuticals North America, Inc. · collab

Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine the short term safety and effectiveness of lubiprostone when used for constipation in adults with cystic fibrosis.

Timeline

Start: 2008-07
Primary completion: 2009-12
Completion: 2009-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Lubiprostone	Small molecule	24 ug	—

Short Term Safety and Efficacy of Lubiprostone in Adults With Cystic Fibrosis

Summary

Timeline

Drugs

Indications